Global mapping of the yeast genetic interaction network AHY Tong, G Lesage, GD Bader, H Ding, H Xu, X Xin, J Young, GF Berriz, ... science 303 (5659), 808-813, 2004 | 2540 | 2004 |
Analysis of β-1, 3-glucan assembly in Saccharomyces cerevisiae using a synthetic interaction network and altered sensitivity to caspofungin G Lesage, AM Sdicu, P Ménard, J Shapiro, S Hussein, H Bussey Genetics 167 (1), 35-49, 2004 | 210 | 2004 |
An interactional network of genes involved in chitin synthesis in Saccharomyces cerevisiae G Lesage, J Shapiro, CA Specht, AM Sdicu, P Ménard, S Hussein, ... BMC genetics 6, 1-16, 2005 | 139 | 2005 |
Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America KA Papp, M Gooderham, J Beecker, CW Lynde, I Delorme, I Dei-Cas, ... BMC dermatology 19, 1-7, 2019 | 8 | 2019 |
Real-world retention and clinical effectiveness of secukinumab for axial spondyloarthritis: results from the Canadian spondyloarthritis research network RD Inman, D Choquette, M Khraishi, DD Gladman, S Hussein, D Neish, ... The Journal of Rheumatology 50 (5), 634-640, 2023 | 3 | 2023 |
Oculomotor analysis to assess brain health: preliminary findings from a longitudinal study of multiple sclerosis using novel tablet-based eye-tracking software É de Villers-Sidani, P Voss, N Bastien, JM Cisneros-Franco, S Hussein, ... Frontiers in Neurology 14, 1243594, 2023 | 1 | 2023 |
Real-World Retention and Clinical Effectiveness of Secukinumab for Psoriatic Arthritis: Results From the Canadian Spondyloarthritis Research Network DD Gladman, D Choquette, M Khraishi, RD Inman, S Hussein, D Neish, ... The Journal of Rheumatology 50 (5), 641-648, 2023 | 1 | 2023 |
P. 028 Eye movement biomarkers for early detection of multiple sclerosis disease progression N Bastien, M Chernock, E De Villers-Sidani, P Voss, F Blanchette, ... Canadian Journal of Neurological Sciences 49 (s1), S15-S15, 2022 | 1 | 2022 |
Secukinumab treated patients in the PURE registry (patients with moderate to severe chronic plaque psoriasis in Latin America and Canada): 18 month follow up data E Mate, K Papp, M Gooderham, C Lynde, R Langley, M Alam, J Beecker, ... AUSTRALASIAN JOURNAL OF DERMATOLOGY 60, 60-60, 2019 | 1 | 2019 |
Real-world safety of secukinumab in patients with moderate to severe chronic plaque psoriasis in Latin America and Canada: results from the PURE registry J Beecker, KA Papp, M Gooderham, V Ho, CW Lynde, M Robern, ... JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 79 (3), AB241-AB241, 2018 | 1 | 2018 |
Secukinumab-treated patients in the PURE registry (Patients with Moderate to Severe Chronic Plaque Psoriasis in Latin America and Canada): 12-month follow-up data CW Lynde, KA Papp, M Gooderham, A Alavi, J Beecker, N Wasel, ... JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 79 (3), AB257-AB257, 2018 | 1 | 2018 |
A Novel Eye Movement Biomarker Application for Monitoring Multiple Sclerosis Disease Progression PS Giacomini, N Bastien, P Voss, S Hussein, F Arseneau, F Blanchette, ... MULTIPLE SCLEROSIS JOURNAL 29, 909-909, 2023 | | 2023 |
Real-world Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results from the CanSpA Research Network RD Inman, D Choquette, M Khraishi, D Gladman, S Hussein, D Neish, ... The Journal of Rheumatology, 2023 | | 2023 |
Real-world 12-month Retention on Secukinumab Among Axial Spondyloarthritis Patients Within the Canadian Spondyloarthritis (CanSpA) Research Network R Inman, D Choquette, M Khraishi, D Gladman, S Hussein, D Neish, ... JOURNAL OF RHEUMATOLOGY 49 (7), 782-783, 2022 | | 2022 |
Real-world 12-month Retention on Secukinumab Among Psoriatic Arthritis Patients Within the Canadian Spondyloarthritis (CanSpA) Research Network D Gladman, D Choquette, M Khraishi, R Inman, S Hussein, D Neish, ... JOURNAL OF RHEUMATOLOGY 49 (7), 786-787, 2022 | | 2022 |
Treatment switch from aflibercept to ranibizumab pre-filled syringe in Canadian nAMD and DME patients in a real-world setting: The PRECISE study S Somani, M Giunta, A Kalevar, R Tuli, L Caron, P Trottier, S Hussein, ... Investigative Ophthalmology & Visual Science 61 (7), 4203-4203, 2020 | | 2020 |
Real-world Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results RD Inman, D Choquette, M Khraishi, D Gladman, S Hussein, D Neish, ... Arthritis Care Res 71, 1285-99, 2019 | | 2019 |
DIAGNOSIS OF PSORIATIC ARTHRITIS IN PATIENTS WITH MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS TREATED WITH SECUKINUMAB VS. OTHER TREATMENTS IN THE PURE REGISTRY: INDICATION OF … K Papp, M Gooderham, J Beecker, C Lynde, I Delorme, I Dei-Cas, ... ACTA DERMATO-VENEREOLOGICA 98, 48-48, 2018 | | 2018 |
Impact socioéconomique réel des traitements du psoriasis au Canada et en Amérique latine: le registre PURE I Delorme, M Gooderham, C Lynde, K Papp, J Beecker, L Albrecht, ... Annales de Dermatologie et de Vénéréologie 144 (12), S226, 2017 | | 2017 |